Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E L Moss

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Antimicrobial Agents and Chemotherapy|February 11, 1992
In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304D Loebenberg, A Cacciapuoti, R Parmegiani, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 19, 2010
Implementing the national invasive cervical cancer audit: a local perspectiveE L Moss, P Pearmain, S Askew, et al.
The Journal of Antibiotics|September 1, 1990
Microbiological and pharmacokinetic studies of acyl demycinosyltylosin and related tylosin derivativesA F Cacciapuoti, D Loebenberg, E L Moss, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and CandidaA Cacciapuoti, D Loebenberg, E Corcoran, et al.
The New England Journal of Medicine|October 22, 2015
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria VaccineD E Neafsey, M Juraska, T Bedford, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Antimicrobial Agents and Chemotherapy|February 11, 1992
In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304D Loebenberg, A Cacciapuoti, R Parmegiani, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 19, 2010
Implementing the national invasive cervical cancer audit: a local perspectiveE L Moss, P Pearmain, S Askew, et al.
The Journal of Antibiotics|September 1, 1990
Microbiological and pharmacokinetic studies of acyl demycinosyltylosin and related tylosin derivativesA F Cacciapuoti, D Loebenberg, E L Moss, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and CandidaA Cacciapuoti, D Loebenberg, E Corcoran, et al.
The New England Journal of Medicine|October 22, 2015
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria VaccineD E Neafsey, M Juraska, T Bedford, et al.
Pageof 5